Titan Pharmaceuticals, Inc.

NasdaqCM:TTNP Voorraadrapport

Marktkapitalisatie: US$3.7m

Titan Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Titan Pharmaceuticals has a total shareholder equity of $4.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.4M and $356.0K respectively.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsration/a
ContantUS$4.09m
AandelenUS$3.99m
Totaal verplichtingenUS$356.00k
Totaal activaUS$4.35m

Recente financiële gezondheidsupdates

Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Jul 10
Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Recent updates

Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Jul 10
Is Titan Pharmaceuticals (NASDAQ:TTNP) In A Good Position To Invest In Growth?

Titan Pharma regains Nasdaq listing compliance

Dec 16

Titan Pharmaceuticals announces 1-for-30 reverse stock split

Nov 30

Titan Pharmaceuticals EPS misses by $0.01, beats on revenue

Nov 16

Titan Pharma closes debt settlement and JT-09 acquisition

Nov 02

Titan Pharma to raise $8M in stock offering

Oct 28

Analyse van de financiële positie

Kortlopende schulden: TTNP's short term assets ($4.4M) exceed its short term liabilities ($356.0K).

Langlopende schulden: TTNP has no long term liabilities.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: TTNP is debt free.

Schuld verminderen: TTNP currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: TTNP has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: TTNP has less than a year of cash runway if free cash flow continues to grow at historical rates of 12.3% each year.


Ontdek gezonde bedrijven